Atossa Therapeutics, Inc. (ATOS)
NCM · Common · CUSIP 04962H506
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ATOS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04962H506 (prev. 04962H209 )
Market Cap
Small Cap
Previous Name
Atossa Genetics, Inc.
Business: Atossa Therapeutics, Inc., the breast health company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.

Company Contact

CEO
Steven C. Quay, M.D. Ph.D.
CFO
Greg Weave
Headquarters
107 Spring Street, Seattle, WA 98104
Phone
206-588-0256 · Toll-Free 800-351-3902
Fax
206-430-1288
Investor Relations
Kyle Guse · 206-325-6086 · info@atossainc.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »